Human PⅠCP(Procollagen Ⅰ C-Terminal Propeptide) ELISA Kit
中文名称:人Ⅰ型前胶原羧基端原肽(PⅠCP)酶联免疫吸附测定试剂盒
别称:
P1CP、C-Propeptide Of Type I Procollagen
Price:
Size:
96T
48T
96T*5
- 反应性: Human
- 检测范围: 0.78-50 ng/mL
- 灵敏度: 0.47 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人PⅠCP抗体包被于酶标板上,实验时样品(或标准品)中的人PⅠCP会与包被抗体结合。后依次加入生物素化的抗人PⅠCP抗体和辣根过氧化物酶标记的亲和素,抗人PⅠCP抗体与结合在包被抗体上的人PⅠCP结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,PⅠCP浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中PⅠCP的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 3.5h |
反应性 | Human |
检测方法 | Colormetric |
检测范围 | 0.78-50 ng/mL |
灵敏度 | 0.47 ng/mL |
样本体积 | 100μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人PⅠCP,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Stiff substrates inhibit collagen accumulation via integrin α2β1, FAK and Src kinases in human atrial fibroblast and myofibroblast cultures derived from patients with aortal stenosis
IF: 7.419Journal:BIOMEDICINE & PHARMACOTHERAPY -
The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
IF: 3.706 -
Matrix Metalloproteinases Increase Because of Hypoperfusion in Obstructive Hypertrophic Cardiomyopathy
IF: 3.639Journal:ANNALS OF THORACIC SURGERY -
Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction
IF: 3.612 -
Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis
IF: 3.367Journal:Frontiers in Physiology -
Increased ratio of sST2/LVMI predicted cardiovascular mortality and heart failure rehospitalization in heart failure with reduced ejection fraction patients: a prospective cohort study
IF: 2.298 -
Extracellular matrix turnover in coronary artery ectasia patients
IF: 2.065Journal:HEART AND VESSELS -
Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy
IF: 1.765Journal:CARDIOVASCULAR PATHOLOGY